Showing results (371-380 of 1,050) with videos related to
Sort By:
Pageof 105
Experimental Brain Research|November 1, 2002
Glutamate excess and free radical formation during and following kainic acid-induced status epilepticusYuto Ueda, Hidekatsu Yokoyama, Akira Nakajima, et al.Brain Research|May 22, 2002
Morphological changes in immunopositive cells of ionotropic glutamate receptor subunits during the development of transplanted fetal ventral mesencephalic neuronsYasushi Ishida, Kazunari Todaka, Hiroyuki Hashiguchi, et al.Microbiology and Immunology|August 23, 2005
Involvement of reactive oxygen intermediate in the enhanced expression of virulence-associated genes of Listeria monocytogenes inside activated macrophagesMasato Makino, Mariko Kawai, Ikuo Kawamura, et al.No Shinkei Geka. Neurological Surgery|August 13, 2005
[Adult choroid plexus papilloma of the posterior fossa: extraventricular location]Tetsuryu Mitsuyama, Mitsunobu Ide, Shinji Hagiwara, et al.Nihon Kyobu Shikkan Gakkai Zasshi|April 1, 1995
[Comparison of complement activation between tuberculous and malignant pleuritis]K Hidaka, M Abe, T Tanaka, et al.Scientific Reports|July 5, 2025
Lung microbiota of patients with ARDS due to coronavirus disease 2019 receiving ECMOYumi Mitsuyama, Kentaro Shimizu, Daisuke Motooka, et al.Auris, Nasus, Larynx|February 21, 2013
Risk factors for olfactory dysfunction in chronic rhinosinusitisEri Mori, Yoshinori Matsuwaki, Chieko Mitsuyama, et al.The Spine Journal : Official Journal of the North American Spine Society|October 12, 2014
Neuroendocrine tumor arising from tailgut cyst with spinal cord tethering: case report and literature reviewTetsuryu Mitsuyama, Motoo Kubota, Yoshiaki Nakamura, et al.Immunopharmacology and Immunotoxicology|January 1, 1989
Contribution of cytokines to time-dependent augmentation of resistance against Listeria monocytogenes after administration of a traditional Chinese medicine, xiao-chai-hu-tang (Japanese name: shosaiko-to)T Kawakita, M Mitsuyama, Y Kumazawa, et al.Japanese Journal of Infectious Diseases|September 12, 2017
Proposed Pharmacokinetic-Pharmacodynamic Breakpoint of Garenoxacin and Other QuinolonesYuka Yamagishi, Tatsuya Shibata, Satoshi Nakagawa, et al.Pageof 105